The company was founded in 2019, and is led by two female entrepreneurs. Today, around 27 million people in the world have severe drug problems and the effects are striking. With a background in the police department, the founders of Eyescanner identified a need for a digital drug test method that can be implemented and used in different kinds of contexts. So, we created Eyescanner Technology.
The research and development is done in collaboration with Sahlgrenska Science Park, Sahlgrenska University Hospital, Evolve technology, Qamcom R&T and RISE. Together, we want to contribute to a positive societal development by providing a faster and less intrusive method that enables early detection, and saves suffering and lives.